您的购物车当前为空
别名 VK-2809
MB-07811 (VK-2809) 是 MB07344 的一种口服活性 HepDirect 前药,具有降低胆固醇和甘油三酯的活性。 MB-07811 是肝脏靶向甲状腺激素受体-β 的激动剂。


为众多的药物研发团队赋能,
让新药发现更简单!
MB-07811 (VK-2809) 是 MB07344 的一种口服活性 HepDirect 前药,具有降低胆固醇和甘油三酯的活性。 MB-07811 是肝脏靶向甲状腺激素受体-β 的激动剂。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 678 | In Stock | |
| 5 mg | ¥ 1,750 | In Stock | |
| 10 mg | ¥ 2,590 | In Stock | |
| 25 mg | ¥ 4,120 | In Stock | |
| 50 mg | ¥ 5,590 | In Stock | |
| 100 mg | ¥ 8,350 | In Stock |
MB-07811 相关产品
| 产品描述 | MB-07811 (VK-2809) is an orally active HepDirect prodrug of MB07344 with cholesterol and triglycerides lowering activity. MB-07811 is an agonist of liver-targeted THR-β. |
| 体外活性 | MB-07811 has a low affinity for thyroid hormone receptors with a Ki of 14.6 μM for TRβ and a Ki of 12.5 μM for TRα[2]. |
| 体内活性 | In diet-induced obese mice, MB-07811 (0.3-30 mg/kg) decreases cholesterol and triglycerides[2]. |
| 别名 | VK-2809 |
| 分子量 | 514.98 |
| 分子式 | C28H32ClO5P |
| CAS No. | 852948-13-1 |
| Smiles | C(OC1=CC(C)=C(CC2=CC(C(C)C)=C(O)C=C2)C(C)=C1)P3(=O)O[C@@H](CCO3)C4=CC(Cl)=CC=C4 |
| 密度 | 1.27 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 45 mg/mL (87.38 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (3.88 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
评论内容